<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01808989</url>
  </required_header>
  <id_info>
    <org_study_id>2013-A00013-42</org_study_id>
    <nct_id>NCT01808989</nct_id>
  </id_info>
  <brief_title>Clinical Interest of the TcPO2 Technique</brief_title>
  <acronym>CINEYSOFT</acronym>
  <official_title>Multicentric Study of the Clinical Interest of the TcPO2 Technique</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The measurement of the transcutaneous oxygen pressure records simultaneously the tcpO2 at the
      buttocks and chest level during walking. Before and after exercise the diagnosis,
      investigations and treatments ongoing or to be performed are recorded.

      The present study focuses on the clinical interest of the transcutaneous oxygen pressure
      during exercise in the diagnosis of claudication in patient referred for an oximetry exercise
      test.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pre-test diagnostic hypothesis with probability will be completed by the physician.

      Pre-test and post test ongoing or scheduled treatments will be completed by the
      physician.After the test, the same post test items will be evaluated.

      Analysis will be done on differences of pre and post test results.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2013</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The percentage of patients for whom results tcpO2 effort led to changes in diagnosis measured by the questionnaire filled by the doctor in charge of the patient before and after the test</measure>
    <time_frame>up to 1 day</time_frame>
    <description>during a walk on a treadmill, there is a DROP of tcpo2&lt;-15</description>
  </primary_outcome>
  <enrollment type="Anticipated">3500</enrollment>
  <condition>Claudication</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise oxymetry</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with buttock pain and referred for an oximetry exercise test
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  referred for an oximetry exercise test

          -  Patient able to walk on a treadmill

          -  Patient covered by the French health insurance

          -  Patient able to understand the protocol

          -  Patient agrees to be involve in the protocol and sign the consent form

        Exclusion Criteria:

          -  any heart issues during the last 3 months

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Abraham, MD; PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University hospital, Angers, FRANCE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre ABRAHAM, MD; Ph.D</last_name>
    <phone>33-(0)-2-41-35-36-10</phone>
    <email>PiAbraham@chu-angers.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Isabelle DURAND ZALESKI, MD; Ph.D</last_name>
    <phone>33-(0)-1-40-27-41-43</phone>
    <email>isabelle.durandzaleski@hmn.aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre ABRAHAM, MD, Ph.D</last_name>
      <phone>33-(0)-2-41--35-36-10</phone>
      <email>PiAbraham@chu-angers.fr</email>
    </contact>
    <contact_backup>
      <last_name>Isabelle DURAND ZALESKI, MD, Ph.D</last_name>
      <phone>33-(0)-40-27-41-43</phone>
      <email>isabelle.durandzaleski@hmn.aphp.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Pierre ABRAHAM, MD, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabelle DURAND ZALESKI, MD, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe LAMOTTE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Christophe LAMOTTE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Lomme</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacques CHEVALIER</last_name>
    </contact>
    <investigator>
      <last_name>Jacques CHEVALIER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Remi LAURENT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabrielle SARLON</last_name>
    </contact>
    <investigator>
      <last_name>Gabrielle SARLON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Antoine PISTORIUS</last_name>
    </contact>
    <investigator>
      <last_name>Marc Antoine PISTORIUS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas BREBION</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillaume MAHE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Guillaume MAHE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandra Bura Riviere, MD PhD</last_name>
    </contact>
    <investigator>
      <last_name>Alessandra BURA RIVIERE, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marion Aubourg, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marion Aubourg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>March 7, 2013</study_first_submitted>
  <study_first_submitted_qc>March 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2013</study_first_posted>
  <last_update_submitted>November 5, 2019</last_update_submitted>
  <last_update_submitted_qc>November 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>peripheral artery disease</keyword>
  <keyword>tcpo2</keyword>
  <keyword>treadmill walking test</keyword>
  <keyword>intermittent claudication</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intermittent Claudication</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

